New spinal anesthesia method could make kidney transplants safer
NCT ID NCT03436368
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares continuous spinal anesthesia to general anesthesia for people receiving a kidney transplant. The goal is to see if the spinal method keeps blood pressure more stable and reduces pain. Sixty adults with end-stage kidney disease are taking part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Bupivacaine and Fentanyl (spinal anesthetic drugs)
- What this could lead to
- If successful, this could offer a safer, more stable anesthesia option for kidney transplant patients, potentially improving recovery and comfort.
- What could go wrong
- This is a small, early-stage study with only 60 participants, so results may not apply to all patients. There are also standard risks of spinal anesthesia, such as headache or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kasr Al-Ainy Hospital, Cairo University
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart pump prevent dangerous drops in blood pressure during C-Sections?
- Can a ketamine boost during surgery slash opioid needs?
- Can a wearable glucose sensor survive the operating room?
- Can a new drug work safely in patients with kidney failure?
- Can a scalp cap read the brain as well as implanted wires?
- What does life feel like for children with a rare birth defect? a new study asks